As we expand the scope of breast-conserving surgery for patients with breast cancer, have we focused too much on the cosmetic results, to the potential detriment of the oncologic outcome? It's a question that concerns some in the field of breast surgery, who believe the evidence to establish clinical efficacy for certain procedures is not yet in. Dr. Monica Morrow, chief of the breast service in the department of surgery, and the Anne Burnett Windfohr Chair of Clinical Oncology at Memorial Sloan-Kettering Cancer Center in New York, joins host Dr. Mark Nolan Hill to explore how we can address the potential pitfalls of emphasizing cosmesis in breast-conserving surgery while maintaining the sound principles of oncologic surgery.
Breast-Conserving Surgery: Curative vs. Cosmetic Outcomes

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
As we expand the scope of breast-conserving surgery for patients with breast cancer, have we focused too much on the cosmetic results, to the potential detriment of the oncologic outcome? It's a question that concerns some in the field of breast surgery, who believe the evidence to establish clinical efficacy for certain procedures is not yet in. Dr. Monica Morrow, chief of the breast service in the department of surgery, and the Anne Burnett Windfohr Chair of Clinical Oncology at Memorial Sloan-Kettering Cancer Center in New York, joins host Dr. Mark Nolan Hill to explore how we can address the potential pitfalls of emphasizing cosmesis in breast-conserving surgery while maintaining the sound principles of oncologic surgery.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?